Advertisement

Reactions Weekly

, Volume 1738, Issue 1, pp 163–163 | Cite as

Lenalidomide

Neutropenia: case report
Case report
  • 17 Downloads

Reference

  1. Dudina G. Evaluation of the efficacy of lenalidomide in patients with high-risk myelodysplastic syndrome (MDS) who are partially resistant to hypomethylating therapy. HemaSphere 2 (Suppl. 2): 946-947 abstr. PB2109, Jun 2018. Available from: URL: http://doi.org/10.1097/HS9.0000000000000060 [abstract] -Russia

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations